| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A03FA04 |
| UNII: | 75473V2YZK |
| InChI Key | GIYAQDDTCWHPPL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H22BrN3O2 |
| Molecular Weight | 344.25 |
| AlogP | 2.11 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 67.59 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Dopamine D2 receptor antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 86 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dyspepsia | 3 | D004415 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 95304 |
| ChEMBL | CHEMBL399510 |
| DrugBank | DB09018 |
| DrugCentral | 406 |
| EPA CompTox | DTXSID0045383 |
| FDA SRS | 75473V2YZK |
| PubChem | 2446 |
| SureChEMBL | SCHEMBL54497 |
| ZINC | ZINC000002038104 |